scholarly journals Pharmacological and clinical profile of indacaterol maleate (Onbrez^|^reg;), an inhaled long-acting ^|^beta;2-adrenoceptor agonist

2012 ◽  
Vol 140 (1) ◽  
pp. 36-43
Author(s):  
Kazuhiko Suzuki ◽  
Masahiko Uchiyama ◽  
Soichiro Matsushima ◽  
Mika Yoshiki ◽  
Tetsuji Kitawaki
Keyword(s):  
Clinical Profile ◽  
Adrenoceptor Agonist ◽  
Beta 2 ◽  
Long Acting

scholarly journals Pharmacological action of SN-408, a novel long-acting selective .BETA.2-adrenoceptor agonist.

1991 ◽  
Vol 98 (1) ◽  
pp. 7-21
Author(s):  
Makoto NISHIMURA ◽  
Masahiko OKIYAMA ◽  
Hajime FUJIWARA ◽  
Mariko KUDO ◽  
Mayumi SIMIZU ◽  
...  
Keyword(s):  
Pharmacological Action ◽  
Adrenoceptor Agonist ◽  
Beta 2 ◽  
Long Acting

scholarly journals Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review

2013 ◽  
pp. 425 ◽  
Author(s):  
Erminia Ridolo ◽  
Montagni ◽  
Olivieri ◽  
Riario-Sforza ◽  
Cristoforo Incorvaia
Keyword(s):  
Beta 2 ◽  
Long Acting

scholarly journals 2. Inhaled Corticosteroids/long Acting ^|^beta;2-agonists Combination.

2010 ◽  
Vol 99 (7) ◽  
pp. 1536-1541
Author(s):  
Mitsuru Adachi ◽  
Takashi Hirose
Keyword(s):  
Inhaled Corticosteroids ◽  
Beta 2 ◽  
Long Acting

Salmeterol post-marketing surveillance: ethical issues

1991 ◽  
Vol 29 (19) ◽  
pp. 75-76
Keyword(s):  
Conventional Treatment ◽  
Ethical Issues ◽  
Surveillance Study ◽  
Preliminary Review ◽  
Adrenoceptor Agonist ◽  
Post Marketing Surveillance ◽  
Post Marketing ◽  
Nationwide Surveillance ◽  
Long Acting

Salmeterol is a long-acting β2 adrenoceptor agonist for inhalation which was introduced last December (Serevent - Allen & Hanburys/ Glaxo). In a preliminary review we concluded that it seemed useful for asthmatics who have symptoms despite conventional treatment including full prophylaxis.1 This article discusses Glaxo’s nationwide surveillance study of salmeterol2 which raises some important issues.

Sign in / Sign up

Export Citation Format

Share Document